Dashmoolaadi kwatha in bronchial asthma(tamak shwasa)
Not yet recruiting
- Conditions
- Diseases of the respiratory system. Ayurveda Condition: TAMAKASVASAH,
- Registration Number
- CTRI/2023/06/054060
- Lead Sponsor
- Someen pant
- Brief Summary
This study is a open label,randomized,parallel group clinical
trial to determine the efficacy of dashmoolaadi kwatha with and without virechana in tamak shwasa (Bronchial Asthma) for the age group between 18-60 years for 45 days.Study will be conducted at UAU, Gurukul Campus, Haridwar on 40 patients. Assessment will be done on the basis of subjective and objective parameters. Study will be conducted at OPD/IPD level of PG department of Kayachikitsa. Assessment will be done at the interval of 15 days of clinical trial and result obtained will be tabulated and statistically analyzed using appropriate tests
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
- Patient having classical features of Tamak Shwasa as mentioned in classics.
- Male or female between the age group 18-60 years.
- Patient fit for Virechana.
Exclusion Criteria
- Patients below 18 years and above 60 years.
- Bronchial asthma associated with complications like emphysema,cor-pulmonale etc.
- Patient suffering from Pulmonary tuberculosis, Lung cancer, Lung fibrosis,Bronchitis Severe attack of asthma Cardiac disease like cardiac asthma, IHD etc.
- Patient suffering from other major medical and psychiatric disorders.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Shleshmanayamuchyamane tu bhrisham bhavati dukhitah (difficult to expectorate) At 1st, 15th & 45th day Ghurgurukam (wheezing sound) At 1st, 15th & 45th day Shayanah shwasa pidatah (Breathlessness during lying position) At 1st, 15th & 45th day Aasinolabhate saukhyam (comfort in sitting posture) At 1st, 15th & 45th day shleshma Vimokshante Muhurtam labhate sukham (momentary releif after expectoration) At 1st, 15th & 45th day Shwasakrichta (difficulty in breathing) At 1st, 15th & 45th day Parsve Avagruhyate (chest tightness) At 1st, 15th & 45th day Ativega kasate (frequent bouts coughing) At 1st, 15th & 45th day
- Secondary Outcome Measures
Name Time Method Peak expiratory flow rate Oxygen saturation
Trial Locations
- Locations (1)
UAU,Gurukul campus, haridwar
🇮🇳Hardwar, UTTARANCHAL, India
UAU,Gurukul campus, haridwar🇮🇳Hardwar, UTTARANCHAL, IndiaSomeen pantPrincipal investigator8755245692pant.drsomeen02@gmail.com